OBESITY AS A RISK FACTOR FOR ENDOMETRIAL PATHOLOGICAL CHANGES
Abstract
According to the World Health Organization, overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. The elevated BMI is a major risk factor for cardiovascular diseases, diabetes, osteoarthritis, some cancers (endometrial, breast, ovarian, prostate, liver, gallbladder, kidney and colon). The most common cause of endometrial hyperplasia is high level of estrogens, combined with insufficient levels of progesterone, which causes secretory changes in the proliferated endometrium from estrogens. This excess endogenous estrogen stimulation can stimulate endometrial proliferation resulting in endometrial hyperplasia and endometrial cancer. The study included a total of 160 respondents. The study group consisted of 120 patients who underwent fractionated explorative curettage due to a medical indication. They were divided into two subgroups: perimenopausal and postmenopausal. The control group consisted of 40 healthy women without fractionated explorative curettage. Anamnestic data were taken from all respondents. Body weight, height and waist circumference were measured in all of the participants. We divided the patients with fractionated explorative curettage into 2 subgroups: with functional and organic changes changes of the endometrium.Patients with explorative curettage had a significantly higher BMI and waist circumference than healthy women. Postmenopausal women had a significantly higher BMI and waist circumference than perimenopausal women. Patients with organic endometrial changes had a significantly higher BMI and waist circumference compared to those with functional changes.
Key words: obesity, endometrial, explorative curettage
References
2. Endometrial hyperplasia. Available at: [http://en.wikipedia.org/wiki/Endometrial_hyperplasia]. Accessed at: 30.10.2023
3. Stojovski M. Benign lesions of the upper part of the genital tract. In: Antovska V. Stojovski M, Gynecology, a textbook intended for medical students, specialists in gynecology and obstetrics and specialist gynecologists-obstetricians. Skopje; 2016, pp: 771-84
4. Exacoustos C, Zupi E, Cangi B, et al. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Ultrasound Obstet Gynecol 1995;6:435-42.
5. Reslova T, Tosner J, Resl M, et al. Endometrial polyps. A clinical study of 245 cases. Arch Gynecol Obstet 1999;262:133-9.
6. Dreisler E, Stampe Sorensen S, Ibsen PH, et al. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 2009;33:102-8
7. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
8. Edman CD, MacDonald PC. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 1978; 130: 456–61
9. Strauss III J, Coutifaris C. The endometrium and myometrium. Regulation and dysfunction. In Yen SSC, Jaffe RB, Barbieri R, editors. Reproductive endocrinology. 4th ed. Philadelphia: WB Saunders Company; 1999. p. 218–231
10. Lépine J, Audet-Walsh E, Grégoire J, et al. Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. J Clin Endocrinol Metab. 2010;95:2689–2698
11. WHO Classification of overweight in adults according to BMI. Available at: [https://www.researchgate.net/figure/WHO-Classification-of-overweight-in-adults-according-to-BMI-1_tbl1_228384706 ] Accessed on 30.10.2023
12. Ozkan NT, Tokmak A, Guzel AI, et al. The association between endometrial polyps and metabolic syndrome: a case-control study Australian and New Zealand Journal of Obstetrics and Gynaecology 2015; 55: 274–8
13. Gul A, Ugur M, Iskender C et al. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters. Arch Gynecol Obstet 2010; 281:479–83
14. Esposito K, Chiodini P, Capuano A, et al. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine 2014;45:28–36
15. Kaya S, Kaya B, Keskin HL, et al. Is there any relationship between benign endometrial pathologies and metabolic status? J Obstet Gynaecol 2019;39(2): 176-83
16. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371: 569–578
17. Aune D, Navarro Rosenblatt DA, Chan DSM, et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol 2015 Aug;26(8):1635-48
18. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 2002; 11: 1531-43
